Economic impact of an ultrasonographic contrast agent on the diagnosis and initial management of patients with suspected renal artery stenosis

Canadian Association of Radiologists Journal

Volumn 53, Issue 4, 2002, Pages 228-236

  Lévesque, Jacques ^a   Lacourcière, Yves ^a   Onrot, John M ^b   Wilson, Stephanie R ^c   Szaky, Esther ^c   Thibodeau, Micheline ^d   Vasilevsky, Murray L ^d   Dashefsky, Sidney M ^e   Allan, Donald R ^e   Lafortune, Michel ^f   Vendeville, Benoît ^f   Zaleski, Witold M ^g   Pagé, Denis E ^g   D'Onofrio, Franco ^h  

^a LAVAL UNIVERSITY   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d MONTREAL GENERAL HOSPITAL   (Canada)

^e HEALTH SCIENCES CENTRE   (Canada)

^f UNIVERSITY OF MONTREAL   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

^h Berlex Canada Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; ECHOGRAPHY; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY SCINTISCANNING; MAJOR CLINICAL STUDY; PATIENT CARE; RESOURCE ALLOCATION; ULTRASOUND;

ADULT; AGED; CONTRAST MEDIA; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; HYPERTENSION, RENOVASCULAR; MALE; MIDDLE AGED; RENAL ARTERY OBSTRUCTION; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 0036775685     PISSN: 08465371     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Conlon PJ, O'Riordan E, Kalra PA. New insights into the epidemiologic and clinical manifestations of atherosclerotic renovascular disease. Am J Kidney Dis 2000;35:573-87.
2. Johansson M, Herlitz H, Jensen G, Rundqvist B, Friberg P. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens 1999;17:1743-50.
3. Radermacher J, Brunkhorst R. Diagnosis and treatment of renovascular stenosis - A cost-benefit analysis. Nephrol Dial Transplant 1998;13:2761-7.
4. Aitchison F, Page A. Diagnostic imaging of renal artery stenosis. J Hum Hypertens 1999;13:595-603.
5. Khairullah QT, Somers DL, Aktay R. Captopril renal scintigraphy in renovascular hypertension. Am Fam Physician 1997;55:2240-4.
6. Pedersen EB. Angiotensin-coverting enzyme inhibitor renography. Pathophysiological, diagnostic and therapeutic aspects in renal artery stenosis. Nephrol Dial Transplant 1994;9:482-92.
7. Lawrence WF, Grist TM, Brazy PC, Fryback DG. Magnetic resonance angiography in progressive renal failure - A technology assessment. Am J Kidney Dis 1995;25:701-9.
8. Dowling RJ, House MK, King PM, Bourke JL, Gibson RN. Contrast-enhanced Doppler ultrasound for renal artery stenosis. Australas Radiol 1999;43:206-9.
9. Lencioni R, Pinto S, Napoli V, Bartolozzi C. Noninvasive assessment of renal artery stenosis: Current imaging protocols and future directions in ultrasonography. J Comput Assist Tomogr 1999;23(Suppl 1):S95-100
10. Missouris CG, Allen CM, Balen FG, Buckenham T, Lees WR, MacGregor GA. Non-invasive screening for renal artery stenosis with ultrasound contrast enhancement. J Hypertens 1996;14:519-24.
11. Blaufox DM. Cost-effectiveness of nuclear medicine procedures in renovascular hypertension. Semin Nucl Med 1989;19:116-21.
12. McNeil BJ, Varady PD, Burrows BA, Adelstein SJ. Cost-effectiveness calculations in the diagnosis and treatment of hypertensive renovascular disease. N Engl J Med 1975;293:216-21.
13. England WL, Grim CE, Weinberger MH, Roberts SD. Cost effectiveness in the detection of renal artery stenosis. J Gen Intern Med 1988;3:344-50.
14. Nelemans PJ, Kessels AGH, De Leeuw P, De Haan M, van Engelshoven J. The cost-effectiveness of the diagnosis of renal artery stenosis. Eur J Radiol 1998;27:95-107.
15. Blaufox DM, Middleton ML, Bongiovanni J, Davis BR. Cost efficacy of the diagnosis and therapy of renovascular hypertension. J Nucl Med 1996;37:171-7.
16. Claudon M, Plouin PF, Baxter GM, Rohban T, Devos DM. Renal arteries in patients at risk of renal arterial stenosis: Multicenter evaluation of the echo-enhancer SH U 508A at color and spectral Doppler US. Radiology 2000;214:739-46.
17. Lacourcière Y, Lévesque J, Cooperberg PL, Onrot JM, Wilson SR, Szaky E, et al. Impact of Levovist ultrasonographic contrast agent on the diagnosis and management of hypertensive patients with suspected renal artery stenosis: A Canadian multicentre pilot study. Can Assoc Radiol J 2002;53:219-27.
18. Tullis MJ, Zierler RE, Glickerman DJ, Bergelin RO, Cantwell-Gab K, Strandness DE Jr. Results of percutaneous transluminal angioplasty for atherosclerotic renal artery stenosis: A follow-up study with duplex ultrasonography. J Vasc Surg 1997;25:46-54.
19. Xue F, Bettman MA, Langdon DR, Wivell WA. Outcome and cost comparison of percutaneous transluminal renal angioplasty, renal arterial stent placement, and renal arterial bypass grafting. Radiology 1999;212:378-84.